Development and evaluation of a dual-target glycoconjugate against Shigella sonnei针对志贺氏菌 Sonnei 的双靶点糖缀合物的开发与评价Frontiers in ImmunologyIF5.92026-09-220OA
Engineering Escherichia coli for increased Und-P availability leads to material improvements in glycan expression technologyMICROBIAL CELL FACTORIESIF4.92024-03-013OA
Development of a novel glycoengineering platform for the rapid production of conjugate vaccines用于快速生产结合疫苗的新型糖工程平台的开发MICROBIAL CELL FACTORIESIF4.92023-08-184OA
Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccinesMICROBIAL CELL FACTORIESIF4.92022-04-2115OA
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coliMICROBIAL CELL FACTORIESIF4.92021-05-249OAAI
Recent advances in the production of recombinant glycoconjugate vaccinesNPJ VACCINESIF6.52019-05-01109OAAI
A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13NPJ VACCINESIF6.52018-10-3149OAAI
Characterization of water and wildlife strains as a subgroup of Campylobacter jejuni using DNA microarraysENVIRONMENTAL MICROBIOLOGYIF42013-03-2617PREAI
The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cellsMEDICAL MICROBIOLOGY AND IMMUNOLOGYIF32011-08-2432PREAI